ARLINGTON, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback